PR88492

DUBAI, UAE, March 14, 2021 /PRNewswire=KYODO JBN/ --

Agiomix has received the ISO 15189:2012 Accreditation from the Emirates

International Accreditation Centre for Next Generation Sequencing clinical

assays.

This makes Agiomix the first and only clinical laboratory in the region to have

both the CAP and ISO 15189 accreditation for its Next Generation Sequencing

(NGS) clinical genetic testing.

Dr. Walaa Allam, Associate Director of Business development at Agiomix

commented, "With this additional reputable international accreditation, Agiomix

now has the unique capacity to offer its healthcare partners and patients,

unparalleled clinical diagnostics services in the area of genetics, we are very

pleased and honored by this accreditation and we look forward to more

international recognition as our services and family grow."

Mr. Saman Setoudeh, Director of Quality Assurance at Agiomix Labs described the

process the lab went through as being "rigorous and detailed", he also

commended the review process and explained that "the ISO accreditation will add

the Lab's strength and ability to lead the area in clinical genetics

applications."

About Agiomix Labs

Agiomix is a leading Clinical Genetics and Specialty Diagnostics Laboratory,

serving patients, healthcare providers and partner laboratories across the

globe, with focus on the Middle East, Africa and Asia markets, Agiomix is both

CAP and ISO 15189 accredited.

www.agiomix.com/

For Media Contacts: Anna Malli, + 971 800-GENOMICS media@agholding.group

Photo - https://mma.prnewswire.com/media/1451421/Agiomix_Labs_Dubai.jpg

SOURCE: AGIOMIX